An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021)

PURPOSE: Genexol-PM is a biodegradable cremophor EL–free polymeric micelle formulation of paclitaxel. Here,we compared efficacy and safety of Genexol-PM plus carboplatin versus Genexol plus carboplatin for ovarian cancer treatment. MATERIALS AND METHODS: In this multicenter, randomized, phase II stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Shin-Wha, Kim, Yong-Man, Cho, Chi Heum, Kim, Young Tae, Kim, Seok Mo, Hur, Soo Young, Kim, Jae-Hoon, Kim, Byoung-Gie, Kim, Seung-Cheol, Ryu, Hee-Sug, Kang, Soon Beom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784626/
https://www.ncbi.nlm.nih.gov/pubmed/28324920
http://dx.doi.org/10.4143/crt.2016.376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784626/
https://www.ncbi.nlm.nih.gov/pubmed/28324920
http://dx.doi.org/10.4143/crt.2016.376

Ejemplares similares